Antenatal corticosteroids to accelerate fetal lung maturation for women at risk of preterm birth
Referencias
Additional references
Barker DJP. Mothers, babies and health in later life. 2nd Edition. London: Churchill Livingstone, 1998.
Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993;341(8841):339‐41.
Block MF, Kling OR, Crosby WM. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant. Obstetrics and Gynecology 1977;50:186‐90.
Clark PM. Programming of the hypothalamo‐pituitary‐adrenal axis and the fetal origins of adult disease hypothesis. European Journal of Pediatrics 1998;157(Suppl 1):S7‐10.
Clarke M, Oxman AD, editors. Cochrane Reviewer's Handbook 4.1 (updated June 2000). In Review Manager (RevMan) [Computer program]. Version 4.1 Oxford, England: The Cochrane Collaboration, 2000.
Clarke M, Oxman AD, editors. Assessment of Study Quality. Cochrane Reviewer's Handbook 4.1 (updated June 2000); Section 6. In Review Manager (RevMan) [Computer program]. Version 4.1 Oxford, England: The Cochrane Collaboration, 2000.
Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. British Journal of Obstetrics and Gynaecology 1990;97:11‐25.
Crowley P. Prophylactic corticosteroids for preterm birth (Cochrane Review). The Cochrane Library 2003, Issue 3.
Crowther CA, Harding J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease (Cochrane review). The Cochrane Library 2003, Issue 3.
Dodic M, Wintour EM, Whitworth JA, Coghlan JP. Effect of steroid hormones on blood pressure. Clinical & Experimental Pharmacology & Physiology 1999;26(7):550‐2.
Doyle LW. Victorian Infant Collaborative Study Group. Outcome at 5 years of age of children 23 to 27 weeks' gestation: refining the prognosis. Pediatrics 2001;108(1):134‐41.
Doyle LW, Casalaz D. Victorian Infant Collaborative Study Group. Outcome at 14 years of extremely low birthweight infants: a regional study. Archives of Diseases in Childhood: Fetal and Neonatal Edition 2001;85(3):F159‐64.
Edwards LJ, Coulter CL, Symonds ME, McMillen IC. Prenatal undernutrition, glucocorticoids and the programming of adult hypertension. Clinical & Experimental Pharmacology & Physiology 2001;28(11):938‐41.
Huang WL, Beazley LD, Quinlivan JA, Evans SF, Nenham JP, Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep. Obstetrics & Gynecology 1999;94(2):213‐8.
Imseis HM, Iams JD. Glucocorticoid use in patients with preterm premature rupture of fetal membranes. Seminars in Perinatology 1996;20(5):439‐50.
Jobe AH, Wada N, Berry LM, Ikegami M, Ervin MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. American Journal of Obstetrics & Gynecology 1998;178(5):880‐5.
Liggins GC. Premature delivery of foetal lambs infused with corticosteroids. Journal of Endocrinology 1969;45:515‐23.
Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50(4):515‐25.
Liggins GC. Prenatal glucocorticoid treatment: prevention of respiratory distress syndrome. Lung maturation and the prevention of hyaline membrane disease. Report of the Seventieth Ross Conference on Pediatric Research; 1976. Columbus, Ohio: Ross Laboratories, 1976:97‐103.
National Institutes of Health (NIH) Consensus Development Conference Statement. Effect of corticosteroids for fetal maturation on perinatal outcomes. American Journal of Obstetrics & Gynecology 1994;173:246‐52.
Padbury JF, Ervin MG, Polk DH. Extrapulmonary effects of antenatally administered steroids. Journal of Pediatrics 1996;128(2):167‐72.
The Cochrane Collaboration. Review Manager (RevMan). Version 4.1 for Windows. Oxford, England: The Cochrane Collaboration, 2000.
Schmidt PL, Sims ME, Strassner HT, Paul RH, Mueller E, McCart D. Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection. American Journal of Obstetrics and Gynecology 1984;148:178‐86.
Schwab M, Roedel M, Akhtar Anwar M, Muler T, Schubert H, Buchwalder LF, et al. Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow. Journal of Physiology 2000;528(3):619‐32.
Seckl JR, Cleasby M, Nyirenda MJ. Glucocorticoids, 11beta‐hydroxysteroid dehydrogenase, and fetal programming. Kidney International 2000;57(4):1412‐7.
Turrentine MA, Wilson PD, Wilkins IA. A retrospective analysis of the effect of antenatal steroid on the incidence of respiratory distress syndrome in preterm twin pregnancies. American Journal of Perinatology 1996;13(6):351‐4.
Vyas J, Kotecha S. Effects of antenatal and postnatal corticosteroids on the preterm lung. Archives of Disease in Childhood: Fetal and Neonatal Edition 1997;77(2):F147‐50.
References to other published versions of this review
Ir a:
Crowley P. Prophylactic corticosteroids for preterm birth (Cochrane Review). The Cochrane Library 2003, Issue 3.
